002007.SZ

Hualan Biological Engineering Inc. [002007.SZ] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

002007.SZ Stock Summary

In the News

002007.SZ Financial details

Company Rating
-
Market Cap
34.47B
Income
1.48B
Revenue
5.33B
Book val./share
-
Cash/share
-
Dividend
0.3
Dividend %
1.46%
Employees
3.71K
Optionable
No
Shortable
Yes
Earnings
22 Apr 2024
P/E
30.1
Forward P/E
-
PEG
7.86
P/S
7.8
P/B
3.42
P/C
-
P/FCF
314.46
Quick Ratio
2.71
Current Ratio
3.88
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.82
EPS next Y
-
EPS next Q
-
EPS this Y
37.29%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
2.67%
Revenue last 5Y
7.44%
Revenue Q/Q
-39.09%
EPS Q/Q
-23.33%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-11.76%
Inst Own
-
Inst Trans
-
ROA
8%
ROE
12%
ROC
0.13%
Gross Margin
68%
Oper. Margin
36%
Profit Margin
26%
Payout
45%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
16.51-25.09
52W High
-43.2%
52W Low
-11.25%
RSI
25
Rel Volume
1.52
Avg Volume
11.01M
Volume
16.76M
Perf Week
-6.89%
Perf Month
-9.15%
Perf Quarter
-
Perf Half Y
-12.45%
-
-
-
-
Beta
0.299
-
-
Volatility
0.36%, 0.28%
Prev Close
-4.12%
Price
14.2
Change
-4.76%

002007.SZ Financial Performance

002007.SZ Dividend History

002007.SZ Frequently Asked Questions

What is Hualan Biological Engineering Inc. stock symbol ?

Hualan Biological Engineering Inc. is a CN stock and trading under the symbol 002007.SZ

What is Hualan Biological Engineering Inc. stock quote today ?

Hualan Biological Engineering Inc. stock price is $14.2 today.

Is Hualan Biological Engineering Inc. stock public?

Yes, Hualan Biological Engineering Inc. is a publicly traded company.

Something similar

Top by Market Cap
AVGO
FXAIX
CMC.DE
JPM
APC.DE
Same Sector
0M40.L
CLCS
BWAY
PDEX
ORTI-A.ST
Same Price Range
4930.TW
PBFS
002041.SZ
NWRN.SW
002009.SZ
Similar Market Cap
SRE
2867.TW
APTV
TCAP-R.BK
0PMJ.L

Company Profile

Healthcare Biotechnology
  • Volume Average 11.01M
  • Market Capitalization 34.47B
  • Employee 3.71K
  • CEO Ms. Bei Fan
  • Headquarters Xinxiang,CN
  • IPO Date 2004-06-25
  • Website https://www.hualanbio.com

Hualan Biological Engineering Inc., a biopharmaceutical company, researches, develops, produces, and commercializes plasma products, viral vaccines, bacterial vaccines, and recombinant proteins and other biologics in the People's Republic of China. Its blood products comprise human albumin, human immunoglobulin, intravenous human immunoglobulin, rabies immunoglobulin, hepatitis B human immunoglobulin, tetanus human immunoglobulin, human prothrombin complex, human coagulation factor VIII, lyophilized human thrombin for external use, freeze-dried human fibrin glue for surgery, and human fibrinogen. The company's vaccines consist of influenza virus split vaccine, recombinant hepatitis B vaccine, ACYW135 meningococcal polysaccharide vaccine, A H1N1 influenza virus split vaccine, and quadrivalent influenza virus split vaccine. The company has strategic alliance with the Chinese Academy of Sciences, and other scientific research institutes and scientific research companies. The company was founded in 1992 and is based in Xinxiang, the People's Republic of China.